94
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD

&
Pages 575-583 | Published online: 01 Mar 2019

References

  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • MiravitllesMEspinosaCFernández-LasoERelationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of bacterial infection in COPDChest19991161404610424501
  • GreenbergSBAllenMWilsonJAtmarRLRespiratory viral infections in adults with and without chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2000162116717310903237
  • SapeyEStockleyRACOPD exacerbations 2: AetiologyThorax200661325025816517585
  • ArturoHErnestoCRosarioMPneumonic and nonpneumonic exacerbations of COPDChest201314441134114223828375
  • MohammadMBHansJVAalimMWCanadian Critical care translational biology group (CCCTBG). Plasma metabolomics for the diagnosis of H1N1 influenza pneumoniaCrit Care2017219728424077
  • WannemacherRWKey role of various individual amino acids in host response to infectionAm J Clin Nutr197730812691280407785
  • AnthonisenNRManfredaJWarrenCPAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
  • Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2398S4015S10843984
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of COPD2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed January 8, 2017
  • Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelinesACCP/AACVPR pulmonary rehabilitation guidelines panel. American College of chest physicians. American Association of cardiovascular and pulmonary rehabilitationChest19971125136313969367481
  • SugawaraKTakahashiHKasaiCEffects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPDRespir Med2010104121883188920627502
  • FerreiraIMBrooksDWhiteJGoldsteinRNutritional supplementation for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev201212CD000998
  • CollinsPFStrattonRJEliaMNutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysisAm J Clin Nutr20129561385139522513295
  • GreeningNJWilliamsJEAHussainSFAn early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trialBMJ2014349g431525004917
  • MatsuiHJoTFushimiKYasunagaHOutcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in JapanRespir Res20171816828431501
  • HelgaSUJamesGMKatherineGDImpact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1997a56794799
  • Japanese Respiratory SocietyThe JRS Guidelines for the Management of COPD 2018Tokyo, JapanJapanese Respiratory Society2018 Japanese
  • Ethical guidelines for medical and health research involving human subjectsMinistry of health, labour and welfare of Japan2015 Available from: http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdfAccessed January 8, 2017
  • StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest200011761638164510858396
  • NiedermanMSMandellLAAnzuetoAGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionAm J Respir Crit Care Med200116371730175411401897
  • MüllerBHarbarthSStolzDDiagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumoniaBMC Infect Dis200771017335562
  • TangWHWangZChoLBrennanDMHazenSLDiminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskJ Am Coll Cardiol200953222061206719477356
  • SapeyEStockleyRACOPD exacerbations. 2: aetiologyThorax200661325025816517585
  • Japanese Respiratory SocietyThe JRS guideline for management of pneumonia in adults 2017Tokyo, JapanJapanese Respiratory Society2017 Japanese
  • ZhangYKobayashiHMawatariKEffects of branched-chain amino acid supplementation on plasma concentrations of free amino acids, insulin, and energy substrates in young menJ Nutr Sci Vitaminol201157111411721512300
  • YonedaTYoshikawaMFuAPlasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary diseaseNutrition2001172959911240335
  • KutsuzawaTShioyaSKuritaDHaidaMPlasma branched-chain amino acid levels and muscle energy metabolism in patients with chronic obstructive pulmonary diseaseClin Nutr200928220320819250720
  • McCowenKCBistrianBRImmunonutrition: problematic or problem solving?Am J Clin Nutr200377476477012663270
  • JonkerRDeutzNEErblandMLAndersonPJEngelenMPAlterations in whole-body arginine metabolism in chronic obstructive pulmonary diseaseAm J Clin Nutr201610361458146427146652
  • WannemacherRWKlainerASDintermanREBeiselWRThe significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infectionAm J Clin Nutr19762999971006822705
  • OliveiraGde AbreuMPelosiPRoccoPExogenous glutamine in respiratory diseases: myth or reality?Nutrients2016827626861387
  • ZhongZWheelerMDLiXL-glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agentCurr Opin Clin Nutr Metab Care20036222924012589194
  • BasavannaSChimalapatiSMaqboolAThe effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulencePLoS One201381e4963823349662
  • LongxiangSHuaLAimeiXDynamic changes in amino acid concentration profiles in patients with sepsisPLoS One201510e012193325849571
  • GulcevMReillyCGriffinTJTryptophan catabolism in acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016112435244627729784
  • SuzukiYSudaTYokomuraKSerum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumoniaJ Infect201119436442
  • ZinelluAFoisAGSotgiaSArginines plasma concentration and oxidative stress in mild to moderate COPDPLoS One2016118e016023727479314
  • BruntonLChabnerBAKnollmanBGoodman and Gilman’s The Pharmacological Basis of Therapeutics12th edNew York, NYMcGraw-Hill Education/Medical2011
  • AgustíAGNogueraASauledaJSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
  • SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
  • DentDLHeylandDKLevyHImmunonutrition may increase mortality in critically ill patients with pneumonia: results of a randomized trialCrit Care Med200230SupplA17
  • HurstJRExacerbation phenotyping in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011184662562621920921
  • ZhouAZhouZZhaoYChenPThe recent advances of phenotypes in acute exacerbations of COPDInt J Chron Obstruct Pulmon Dis2017121009101828392685